Katherine Ratliff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katherine Ratliff has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Michael Worth Calfee
US Environmental Protection Agency, Research Triangle Park, North Carolina, 27711, USA.
11 shared publications - Lukas Oudejans
Center for Environmental Solutions and Emergency Response (CESER), Office of Research and Development, U.S. Environmental Protection Agency (ORD/USEPA), Research Triangle Park, NC, USA
7 shared publications - Anne M. Mikelonis
U.S. Environmental Protection Agency Durham North Carolina USA
6 shared publications - A. Brad Murray
Division of Earth and Climate Sciences Nicholas School of the Environment Duke University Durham NC USA
4 shared publications Abderrahmane Touati
Jacobs Technology Inc., Research Triangle Park, NC, USA
4 shared publicationsMariela Monge
Eastern Research Group, Inc., Research Triangle Park
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- p. 1-15
Germicidal ultraviolet to reduce transmission of respiratory infections indoors: a systematic review
Background: Respiratory infections that transmit through air contribute substantially to global morbidity and mortality. Although preclinical data on germicidal ultraviolet (GUV) for air treatment are promising, its real-world effectiveness remains incompletely understood. Purpose: Review effectiveness and safety of GUV for preventing respiratory infection transmission. Data sources: Medline, Embase, Global Health, Cochrane Library, CINAHL, Engineering Village, Epistemonikos, Scopus, and Environmental Science Collection from inception through December 2025. Study selection: Studies of GUV with a comparator, measuring human outcomes including respiratory infections, absenteeism, or adverse events. Data extraction: At least two investigators extracted data. Data synthesis: We identified 57 reports describing 40 studies published between 1940 and 2025: 30 non-randomized controlled trials, 4 randomized controlled trials (RCTs), 4 case series, 1 cohort study, and 1 cross-sectional study. Non-randomized studies indicated GUV reduces infections with high transmissibility through air (measles and chickenpox), although results were mixed for undifferentiated respiratory illnesses and absenteeism. Two RCTs were inconclusive or showed only modest effects. Safety monitoring in 16 studies identified no increased eye or skin irritation from properly installed GUV. All studies had at least one threat to validity; 89% were non-randomized, and 83% lacked statistical power calculations. Limitations: Heterogeneous study designs, interventions, and outcomes precluded meta-analysis. Conclusions: Several older clinical studies indicated that GUV reduces infections with high transmissibility through air, but its broader effectiveness against respiratory infection remains uncertain. Inconclusive results may reflect methodological and epidemiological limitations rather than true ineffectiveness. Adequately powered RCTs with robust clinical endpoints are needed. Registration: https://osf.io/fg6qx
- 26 October 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- p. 1-15
Open AccessGermicidal ultraviolet to reduce transmission of respiratory infections indoors: a systematic review
Background: Respiratory infections that transmit through air contribute substantially to global morbidity and mortality. Although preclinical data on germicidal ultraviolet (GUV) for air treatment are promising, its real-world effectiveness remains incompletely understood. Purpose: Review effectiveness and safety of GUV for preventing respiratory infection transmission. Data sources: Medline, Embase, Global Health, Cochrane Library, CINAHL, Engineering Village, Epistemonikos, Scopus, and Environmental Science Collection from inception through December 2025. Study selection: Studies of GUV with a comparator, measuring human outcomes including respiratory infections, absenteeism, or adverse events. Data extraction: At least two investigators extracted data. Data synthesis: We identified 57 reports describing 40 studies published between 1940 and 2025: 30 non-randomized controlled trials, 4 randomized controlled trials (RCTs), 4 case series, 1 cohort study, and 1 cross-sectional study. Non-randomized studies indicated GUV reduces infections with high transmissibility through air (measles and chickenpox), although results were mixed for undifferentiated respiratory illnesses and absenteeism. Two RCTs were inconclusive or showed only modest effects. Safety monitoring in 16 studies identified no increased eye or skin irritation from properly installed GUV. All studies had at least one threat to validity; 89% were non-randomized, and 83% lacked statistical power calculations. Limitations: Heterogeneous study designs, interventions, and outcomes precluded meta-analysis. Conclusions: Several older clinical studies indicated that GUV reduces infections with high transmissibility through air, but its broader effectiveness against respiratory infection remains uncertain. Inconclusive results may reflect methodological and epidemiological limitations rather than true ineffectiveness. Adequately powered RCTs with robust clinical endpoints are needed. Registration: https://osf.io/fg6qx
- 7 April 2026
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 60 (15) , 11202-11217
Exploring Surrogate Selection for Virucidal Aerosol Testing: A Qualitative Analysis
The COVID-19 pandemic heightened interest in the development and testing of virucidal chemistries and technologies for use in indoor environments. Direct testing of pathogens often requires a high-level biosafety containment, which can restrict performance evaluations to smaller scales that may have limited translatability to the complexities of real-world indoor environments. Therefore, using viral surrogates that are safer to work with than target pathogens offers many potential benefits, including aerosol testing in more realistic conditions. This scoping review analyzes surrogate selection and use across aerosol, surface, and suspension-based tests and identifies bridges in surrogate selection considerations. A qualitative analysis of 133 studies was conducted to highlight trends, knowledge gaps, and future directions toward standardized surrogate selection frameworks. This review finds that Enterobacteria phage MS2 (MS2) and other bacteriophages are commonly used due to their practicality and safety. There are limited examples of concurrent pathogen and surrogate testing to assess suitability, which is highly context-dependent on the test conditions. Beyond virucide testing, the surrogate selection considerations discussed herein are informative for research on the persistence, transmission, transport, behavior, and nonchemical management of airborne viruses.
- 7 April 2026
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 60 (15) , 11202-11217
Exploring Surrogate Selection for Virucidal Aerosol Testing: A Qualitative Analysis
The COVID-19 pandemic heightened interest in the development and testing of virucidal chemistries and technologies for use in indoor environments. Direct testing of pathogens often requires a high-level biosafety containment, which can restrict performance evaluations to smaller scales that may have limited translatability to the complexities of real-world indoor environments. Therefore, using viral surrogates that are safer to work with than target pathogens offers many potential benefits, including aerosol testing in more realistic conditions. This scoping review analyzes surrogate selection and use across aerosol, surface, and suspension-based tests and identifies bridges in surrogate selection considerations. A qualitative analysis of 133 studies was conducted to highlight trends, knowledge gaps, and future directions toward standardized surrogate selection frameworks. This review finds that Enterobacteria phage MS2 (MS2) and other bacteriophages are commonly used due to their practicality and safety. There are limited examples of concurrent pathogen and surrogate testing to assess suitability, which is highly context-dependent on the test conditions. Beyond virucide testing, the surrogate selection considerations discussed herein are informative for research on the persistence, transmission, transport, behavior, and nonchemical management of airborne viruses.
- 16 October 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (42) , 22651-22662
Inactivation Challenges of SARS-CoV-2 on Surfaces in the Built Environment by Irradiation from Pulse Xenon, 275 nm Light-Emitting-Diode, and Far-Ultraviolet Sources
Motivated by the COVID-19 pandemic, laboratory tests were conducted to evaluate ultraviolet-C (UVC) radiation-emitting devices that are potentially capable of inactivating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on surfaces common to the built environment. In this study, we evaluated the efficacy of three UVC radiation-emitting devices: a pulsed xenon light, a 275 nm LED, and a 222 nm far-UVC light. Experiments were conducted using virus-containing droplets in either tissue culture media or simulated saliva inoculated onto the materials. UVC radiation was significantly more effective in the inactivation of SARS-CoV-2 on hard nonporous surfaces versus porous surfaces; more effective in wet droplets versus dried droplets, while the inoculum type had less of an impact. These observations are partially supported by UVC absorption measurements of the inoculum, which indicated a higher UVC absorption for simulated saliva versus tissue culture media. Absorption spectra for dried inoculum were identical between 260 and 280 nm, with higher absorbances for tissue culture media versus simulated saliva for shorter wavelengths. The observed reduction in efficacy from laboratory conditions (wet, tissue culture media in, e.g., Petri dishes) to more realistic conditions (dried, simulated saliva droplets) indicates that the implementation of UVC radiation leading to an effective risk reduction remains challenging for surface treatment.
- 16 October 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (42) , 22651-22662
Inactivation Challenges of SARS-CoV-2 on Surfaces in the Built Environment by Irradiation from Pulse Xenon, 275 nm Light-Emitting-Diode, and Far-Ultraviolet Sources
Motivated by the COVID-19 pandemic, laboratory tests were conducted to evaluate ultraviolet-C (UVC) radiation-emitting devices that are potentially capable of inactivating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on surfaces common to the built environment. In this study, we evaluated the efficacy of three UVC radiation-emitting devices: a pulsed xenon light, a 275 nm LED, and a 222 nm far-UVC light. Experiments were conducted using virus-containing droplets in either tissue culture media or simulated saliva inoculated onto the materials. UVC radiation was significantly more effective in the inactivation of SARS-CoV-2 on hard nonporous surfaces versus porous surfaces; more effective in wet droplets versus dried droplets, while the inoculum type had less of an impact. These observations are partially supported by UVC absorption measurements of the inoculum, which indicated a higher UVC absorption for simulated saliva versus tissue culture media. Absorption spectra for dried inoculum were identical between 260 and 280 nm, with higher absorbances for tissue culture media versus simulated saliva for shorter wavelengths. The observed reduction in efficacy from laboratory conditions (wet, tissue culture media in, e.g., Petri dishes) to more realistic conditions (dried, simulated saliva droplets) indicates that the implementation of UVC radiation leading to an effective risk reduction remains challenging for surface treatment.
- 23 June 2025
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 78 (7)
Impact of inoculum composition on bacteria and bacteriophage UVC inactivation at 222 nm and 254 nm
Using technologies that emit ultraviolet-C (UVC) radiation to inactivate pathogens has gained increasing interest as a strategy for reducing the risk of disease transmission, but it can be difficult to predict their performance in applied settings. Directly irradiating occupied spaces with emerging far-UVC has been proposed, as its shorter wavelength (200–230 nm) is reportedly less damaging to human eyes and skin than longer wavelengths. In this study, we conducted surface tests to evaluate the impact of different inoculum compositions (with and without soil loads) and conditions (wet vs. dried droplets) to determine how these factors affect the efficacy of UVC sources with peak emissions at 254 and 222 nm against five bacteria and two bacteriophages. The presence of a soil load reduced the efficacy of 222-nm UVC more than that at 254 nm, and both UVC sources were generally less effective against microbes in dried (vs. wet) inoculum. Given that pathogens will often be exposed to UVC in the presence of proteins, salts, and other constituents depending on how they are emitted, it is important to consider these challenges when quantifying efficacy.
- 23 June 2025
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 78 (7)
Impact of inoculum composition on bacteria and bacteriophage UVC inactivation at 222 nm and 254 nm
Using technologies that emit ultraviolet-C (UVC) radiation to inactivate pathogens has gained increasing interest as a strategy for reducing the risk of disease transmission, but it can be difficult to predict their performance in applied settings. Directly irradiating occupied spaces with emerging far-UVC has been proposed, as its shorter wavelength (200–230 nm) is reportedly less damaging to human eyes and skin than longer wavelengths. In this study, we conducted surface tests to evaluate the impact of different inoculum compositions (with and without soil loads) and conditions (wet vs. dried droplets) to determine how these factors affect the efficacy of UVC sources with peak emissions at 254 and 222 nm against five bacteria and two bacteriophages. The presence of a soil load reduced the efficacy of 222-nm UVC more than that at 254 nm, and both UVC sources were generally less effective against microbes in dried (vs. wet) inoculum. Given that pathogens will often be exposed to UVC in the presence of proteins, salts, and other constituents depending on how they are emitted, it is important to consider these challenges when quantifying efficacy.
- 20 February 2025
- Published by American Chemical Society (ACS) in ACS ES&T Air
- Vol. 2 (3) , 368-377
Factors Affecting Reduction of Infectious Aerosols by Far-UVC and Portable HEPA Air Cleaners
Technologies that can reduce concentrations of airborne microorganisms through either particle capture or inactivation are important tools for reducing the risk of disease transmission and improving overall indoor air quality. The effectiveness of these technologies is tested in different ways, and as a result, it is challenging to compare results and optimize their use in applied settings. In this study, experiments were conducted in a large bioaerosol chamber to evaluate the efficacy of far-UVC and portable HEPA air cleaners against the bacteriophage MS2 as a surrogate for human viral pathogens. For both technologies, changing the media used to aerosolize the microorganism from deionized water to a simulated saliva doubled effectiveness metrics (both log10 reductions and clean air delivery rates). Because reductions did not follow first order, log–linear dynamics, using different segments of the test period to calculate efficacy also significantly impacted reported performance. Evidence shown here indicates that both microbiological and particle dynamics likely play a role in impacting test outcomes under current methods, and more research is needed to improve repeatable and reliable standardized approaches for determining technology performance against infectious aerosols.
- 20 February 2025
- Published by American Chemical Society (ACS) in ACS ES&T Air
- Vol. 2 (3) , 368-377
Factors Affecting Reduction of Infectious Aerosols by Far-UVC and Portable HEPA Air Cleaners
Technologies that can reduce concentrations of airborne microorganisms through either particle capture or inactivation are important tools for reducing the risk of disease transmission and improving overall indoor air quality. The effectiveness of these technologies is tested in different ways, and as a result, it is challenging to compare results and optimize their use in applied settings. In this study, experiments were conducted in a large bioaerosol chamber to evaluate the efficacy of far-UVC and portable HEPA air cleaners against the bacteriophage MS2 as a surrogate for human viral pathogens. For both technologies, changing the media used to aerosolize the microorganism from deionized water to a simulated saliva doubled effectiveness metrics (both log10 reductions and clean air delivery rates). Because reductions did not follow first order, log–linear dynamics, using different segments of the test period to calculate efficacy also significantly impacted reported performance. Evidence shown here indicates that both microbiological and particle dynamics likely play a role in impacting test outcomes under current methods, and more research is needed to improve repeatable and reliable standardized approaches for determining technology performance against infectious aerosols.
- 3 October 2024
- Published by Elsevier in Journal of Environmental Management
- Vol. 370, 122711
Comparison of liquid and filter sampling techniques for recovery of Bacillus spores and Escherichia coli from environmental water
- 3 October 2024
- Published by Elsevier in Journal of Environmental Management
- Vol. 370, 122711
Comparison of liquid and filter sampling techniques for recovery of Bacillus spores and Escherichia coli from environmental water
- Open Access
- 13 February 2024
- Published by Elsevier in Journal of Environmental Management
- Vol. 354, 120286
The potential to manage releases of Bacillus anthracis using bioretention and a high flow media filter: Results of simulated runoff testing with tracer spores Bacillus globigii
- 13 February 2024
- Published by Elsevier in Journal of Environmental Management
- Vol. 354, 120286
Open AccessThe potential to manage releases of Bacillus anthracis using bioretention and a high flow media filter: Results of simulated runoff testing with tracer spores Bacillus globigii
- 9 October 2023
- Published by Taylor & Francis in Aerosol Science and Technology
- Vol. 57 (12) , 1178-1185
Impact of test methodology on the efficacy of triethylene glycol (Grignard Pure) against bacteriophage MS2
The COVID-19 pandemic has raised interest in using chemical air treatments as part of a strategy to reduce the risk of disease transmission, but more information is needed to characterize their efficacy at scales translatable to applied settings and to develop standardized test methods for characterizing the performance of these products. Grignard Pure, a triethylene glycol (TEG) active ingredient air treatment, was evaluated using two different test protocols in a large bioaerosol test chamber and observed to inactivate bacteriophage MS2 in air (up to 99.9% at 90 min) and on surfaces (up to 99% at 90 min) at a concentration of approximately 1.2 - 1.5 mg/m3. Introducing bioaerosol into a TEG-charged chamber led to overall greater reductions compared to when TEG was introduced into a bioaerosol-charged chamber, although the differences in efficacy against airborne MS2 were only significant in the first 15 min. Time-matched control conditions (no TEG present) and replicate tests for each condition were essential for characterizing treatment efficacy. These findings suggest that chemical air treatments could be effective in reducing the air and surface concentrations of infectious pathogens in occupied spaces, although standard methods are needed for evaluating their efficacy and comparing results across studies. The potential health impacts of chronic exposure to chemicals should also be considered, but those were not evaluated here.
- 9 October 2023
- Published by Taylor & Francis in Aerosol Science and Technology
- Vol. 57 (12) , 1178-1185
Impact of test methodology on the efficacy of triethylene glycol (Grignard Pure) against bacteriophage MS2
The COVID-19 pandemic has raised interest in using chemical air treatments as part of a strategy to reduce the risk of disease transmission, but more information is needed to characterize their efficacy at scales translatable to applied settings and to develop standardized test methods for characterizing the performance of these products. Grignard Pure, a triethylene glycol (TEG) active ingredient air treatment, was evaluated using two different test protocols in a large bioaerosol test chamber and observed to inactivate bacteriophage MS2 in air (up to 99.9% at 90 min) and on surfaces (up to 99% at 90 min) at a concentration of approximately 1.2 - 1.5 mg/m3. Introducing bioaerosol into a TEG-charged chamber led to overall greater reductions compared to when TEG was introduced into a bioaerosol-charged chamber, although the differences in efficacy against airborne MS2 were only significant in the first 15 min. Time-matched control conditions (no TEG present) and replicate tests for each condition were essential for characterizing treatment efficacy. These findings suggest that chemical air treatments could be effective in reducing the air and surface concentrations of infectious pathogens in occupied spaces, although standard methods are needed for evaluating their efficacy and comparing results across studies. The potential health impacts of chronic exposure to chemicals should also be considered, but those were not evaluated here.
- Open Access
- 1 March 2023
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 134 (3)
Evaluation of steam heat as a decontamination approach for SARS-CoV-2 when applied to common transit-related materials
The purpose of this study was to evaluate the efficacy of steam heat for inactivation of SARS-CoV-2 when applied to materials common in mass transit installations. SARS CoV-2 (USA-WA1/2020) was resuspended in either cell culture media or synthetic saliva, inoculated (∼1 × 106 TCID50) onto porous and nonporous materials and subjected to steam inactivation efficacy tests as either wet or dried droplets. The inoculated test materials were exposed to steam heat ranging from 70°C to 90°C. The amount of infectious SARS-CoV-2 remaining after various exposure durations ranging from 1 to 60 s was assessed. Higher steam heat application resulted in higher inactivation rates at short contact times. Steam applied at 1-inch distance (∼90°C at the surface) resulted in complete inactivation for dry inoculum within 2 s of exposure (excluding two outliers of 19 test samples at the 5-s duration) and within 2–30 s of exposure for wet droplets. Increasing the distance to 2 inches (∼70°C) also increased the exposure time required to achieve complete inactivation to 15 or 30 s for materials inoculated with saliva or cell culture media, respectively. Steam heat can provide high levels of decontamination (>3 log reduction) for transit-related materials contaminated with SARS-CoV-2 using a commercially available steam generator with a manageable exposure time of 2–5 s.
- 1 March 2023
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 134 (3)
Open AccessEvaluation of steam heat as a decontamination approach for SARS-CoV-2 when applied to common transit-related materials
The purpose of this study was to evaluate the efficacy of steam heat for inactivation of SARS-CoV-2 when applied to materials common in mass transit installations. SARS CoV-2 (USA-WA1/2020) was resuspended in either cell culture media or synthetic saliva, inoculated (∼1 × 106 TCID50) onto porous and nonporous materials and subjected to steam inactivation efficacy tests as either wet or dried droplets. The inoculated test materials were exposed to steam heat ranging from 70°C to 90°C. The amount of infectious SARS-CoV-2 remaining after various exposure durations ranging from 1 to 60 s was assessed. Higher steam heat application resulted in higher inactivation rates at short contact times. Steam applied at 1-inch distance (∼90°C at the surface) resulted in complete inactivation for dry inoculum within 2 s of exposure (excluding two outliers of 19 test samples at the 5-s duration) and within 2–30 s of exposure for wet droplets. Increasing the distance to 2 inches (∼70°C) also increased the exposure time required to achieve complete inactivation to 15 or 30 s for materials inoculated with saliva or cell culture media, respectively. Steam heat can provide high levels of decontamination (>3 log reduction) for transit-related materials contaminated with SARS-CoV-2 using a commercially available steam generator with a manageable exposure time of 2–5 s.